SG11202104948QA - Process for safely providing retinal phototherapy based on determination of rpe melanin levels - Google Patents

Process for safely providing retinal phototherapy based on determination of rpe melanin levels

Info

Publication number
SG11202104948QA
SG11202104948QA SG11202104948QA SG11202104948QA SG11202104948QA SG 11202104948Q A SG11202104948Q A SG 11202104948QA SG 11202104948Q A SG11202104948Q A SG 11202104948QA SG 11202104948Q A SG11202104948Q A SG 11202104948QA SG 11202104948Q A SG11202104948Q A SG 11202104948QA
Authority
SG
Singapore
Prior art keywords
determination
melanin levels
safely providing
rpe melanin
retinal phototherapy
Prior art date
Application number
SG11202104948QA
Inventor
David B Chang
Jeffrey K Luttrull
Original Assignee
Ojai Retinal Technology Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/203,970 external-priority patent/US10952899B2/en
Priority claimed from US16/241,812 external-priority patent/US10434330B2/en
Application filed by Ojai Retinal Technology Llc filed Critical Ojai Retinal Technology Llc
Publication of SG11202104948QA publication Critical patent/SG11202104948QA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
    • A61B3/12—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for looking at the eye fundus, e.g. ophthalmoscopes
    • A61B3/1225—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for looking at the eye fundus, e.g. ophthalmoscopes using coherent radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/008—Methods or devices for eye surgery using laser
    • A61F9/00821—Methods or devices for eye surgery using laser for coagulation
    • A61F9/00823—Laser features or special beam parameters therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/008—Methods or devices for eye surgery using laser
    • A61F2009/00844—Feedback systems
    • A61F2009/00851—Optical coherence topography [OCT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/008—Methods or devices for eye surgery using laser
    • A61F2009/00861—Methods or devices for eye surgery using laser adapted for treatment at a particular location
    • A61F2009/00863—Retina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/008—Methods or devices for eye surgery using laser
    • A61F2009/00878—Planning
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0626—Monitoring, verifying, controlling systems and methods
    • A61N2005/0627—Dose monitoring systems and methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pathology (AREA)
  • Optics & Photonics (AREA)
  • Vascular Medicine (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Eye Examination Apparatus (AREA)
SG11202104948QA 2018-11-29 2019-04-29 Process for safely providing retinal phototherapy based on determination of rpe melanin levels SG11202104948QA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16/203,970 US10952899B2 (en) 2017-11-20 2018-11-29 Process for adjusting treatment parameters for retina phototherapy based on RPE melanin levels
US16/241,812 US10434330B2 (en) 2017-11-20 2019-01-07 Process for safely providing retinal phototherapy based on determination of RPE melanin levels
PCT/US2019/029660 WO2020112164A1 (en) 2018-11-29 2019-04-29 Process for safely providing retinal phototherapy based on determination of rpe melanin levels

Publications (1)

Publication Number Publication Date
SG11202104948QA true SG11202104948QA (en) 2021-06-29

Family

ID=70852415

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202104948QA SG11202104948QA (en) 2018-11-29 2019-04-29 Process for safely providing retinal phototherapy based on determination of rpe melanin levels

Country Status (8)

Country Link
EP (1) EP3880301A4 (en)
JP (1) JP7327832B2 (en)
CN (1) CN113474041A (en)
AU (1) AU2019386705B2 (en)
BR (1) BR112021009787A2 (en)
CA (1) CA3116688A1 (en)
SG (1) SG11202104948QA (en)
WO (1) WO2020112164A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2578064C (en) * 2004-08-23 2015-10-13 Sylentis S.A.U. Treatment of eye disorders characterized by an elevated intraocular pressure by sirnas
US20070213693A1 (en) * 2004-08-27 2007-09-13 Ellex Medical Pty Ltd Selective ophthalmic laser treatment
US20110306919A1 (en) 2008-01-18 2011-12-15 Latina Mark A Selective Photostimulation to Induce Cell Proliferation
US10194798B1 (en) * 2017-11-20 2019-02-05 Ojai Retinal Technology, Llc Measuring RPE and choroid melanin levels with reflectometer
JP6766449B2 (en) * 2016-05-26 2020-10-14 株式会社ニデック Medical devices and programs

Also Published As

Publication number Publication date
JP2022513576A (en) 2022-02-09
BR112021009787A2 (en) 2021-08-17
EP3880301A1 (en) 2021-09-22
WO2020112164A1 (en) 2020-06-04
AU2019386705B2 (en) 2023-11-09
EP3880301A4 (en) 2022-01-19
CA3116688A1 (en) 2020-06-04
JP7327832B2 (en) 2023-08-16
AU2019386705A1 (en) 2021-07-15
CN113474041A (en) 2021-10-01

Similar Documents

Publication Publication Date Title
IL276398A (en) Combination therapy for the treatment of mastocytosis
IL277333A (en) Methods for treating ocular diseases
EP3749264C0 (en) Laser therapy for treatment and prevention of eye diseases
PL3122878T3 (en) Mrna therapy for the treatment of ocular diseases
IL276383B1 (en) Treatment of ophthalmologic diseases
EP3240612A4 (en) Methods of treating retinal diseases
EP3876712C0 (en) Screening methods for treatments of intraocular diseases or disorders
IL268357A (en) Photoreceptor cells for the treatment of retinal diseases
IL267229A (en) Methods of treating ocular disorders
IL282643A (en) Combination therapy for treatment of hematological diseases
IL281736A (en) Methods of treating myeloproliferative disorders
ZA202002075B (en) Compounds, compositions and methods for treatment of eye disorders and skin diseases
MX2019014024A (en) Treatment of depressive disorders.
IL269698B (en) Methods of preventing or treating ophthalmic diseases
GB202015959D0 (en) Treatment of diseases involving NAD
SG11202001595SA (en) Angio-3 for treatment of retinal angiogenic diseases
IL259381B (en) Mirabegron for the treatment of retinal diseases
SG11202104948QA (en) Process for safely providing retinal phototherapy based on determination of rpe melanin levels
IL289436A (en) Methods for treating ocular diseases
IL282898A (en) Ophthalmic compositions and methods for the treatment of skin diseases and eye diseases
PL3407879T3 (en) Ophthalmic gabapentin for the treatment of corneal ulcers
EP3302382A4 (en) Implant for treatment of an ocular condition
IL281589A (en) Methods of treating myeloproliferative disorders
SG11202105023UA (en) System and process for adjusting treatment parameters for retina phototherapy based on rpe melanin levels
EP3518913A4 (en) Methods for treating ocular diseases